SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Aesthetic Medical International Holdings Group Ltd. – ‘6-K’ for 3/8/24

On:  Friday, 3/8/24, at 5:25pm ET   ·   For:  3/8/24   ·   Accession #:  1104659-24-32491   ·   File #:  1-39088

Previous ‘6-K’:  ‘6-K’ on 12/13/23 for 12/12/23   ·   Next & Latest:  ‘6-K’ on / for 4/25/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/08/24  Aesthetic Medical Int’l Hold… Ltd 6-K         3/08/24    2:17K                                    Toppan Merrill/FA

Current, Quarterly or Annual Report by a Foreign Issuer   —   Form 6-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 6-K         Current, Quarterly or Annual Report by a Foreign    HTML      9K 
                Issuer                                                           
 2: EX-99.1     Miscellaneous Exhibit                               HTML      9K 


‘6-K’   —   Current, Quarterly or Annual Report by a Foreign Issuer


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of March 2024

 

Commission File Number: 001-39088

 

Aesthetic Medical International Holdings Group Limited

 

1122 Nanshan Boulevard
Nanshan District, Shenzhen
Guangdong Province, China 518052

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

  Form 20-F  x Form 40-F  ¨  

 

 

 

 

 

EXHIBIT INDEX

 

Exhibit No.   Description
99.1   Press Release - Aesthetic Medical International Holdings Group Ltd. Announces Receipt of a Letter of Expected Delisting Determination From Nasdaq Staff and Intention to Request a Hearing before the Nasdaq Hearings Panel

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 Date: March 8, 2024 Aesthetic Medical International Holdings Group Limited
   
  By: /s/ Guanhua Wu
  Name: Guanhua Wu
  Title: Chief Financial Officer

 

 

Top
Filing Submission 0001104659-24-032491   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 5:31:29.1am ET